Wilson Sonsini Goodrich & Rosati advised JP Morgan Life Sciences Private Capital on the transaction. Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
